New psychoactive substances are becoming increasingly common in many parts of the world, and some of them are marketed as “legal highs” and are produced to circumvent the drug legislation, and they come in many unregulated forms. The aim of this research was to characterize the metabolites of a new psychoactive substance and hence provide the fundamental data needed for further research of toxicity and future drug testing. The synthetic cannabinoid 4-fluoro-CUMYL-5-fluoro-PICA was incubated in cryopreserved hepatocytes for 1, 3 and 5 hour and then the formed metabolites was analyzed with an LC-QTOF-MS method, data analysis was performed by using the software MassHunter Qualitative Analysis. For 4-fluoro-CUMYL-5-fluoro-PICA a total of ten me...
Synthetic cannabinoids are one of the most significant groups within the category new psychoactive s...
Recently, use of novel synthetic cannabinoids has increased greatly despite worldwide efforts to reg...
Synthesized in early 1990s in pharmaceutical research, designer cannabinoids show high affinity at e...
New psychoactive substances are becoming increasingly common in many parts of the world, and some of...
The main analytical targets of synthetic cannabinoids are often metabolites. With the high number of...
Synthetic cannabinoids (SCs) represented 45% of new psychoactive substances seizures in Europe (data...
Synthetic cannabinoids (SCs) represented 45% of new psychoactive substances seizures in Europe (data...
New psychoactive substances (NPS) are emerging in the illegal drug market, which has led to major ch...
Synthetic cannabinoids are a class of novel psychoactive substances originally developed to explore ...
Clandestine laboratories continue producing new synthetic cannabinoids that mimic and magnify natura...
noids have been abused as recreational drugs, prompt-ing scheduling of these substances in many coun...
Purpose New generations of synthetic cannabinoids (SCs) have recognized strong psychoactive effects,...
The drug abuse epidemic within the United States remains one of the nation’s most serious social cha...
ADB-CHMINACA (MAB-CHMINACA) is a new synthetic cannabinoid with high potency and many reported adver...
BACKGROUND: ADB-PINACA and its 5-fluoropentyl analog 5F-ADB-PINACA are among the most potent synthet...
Synthetic cannabinoids are one of the most significant groups within the category new psychoactive s...
Recently, use of novel synthetic cannabinoids has increased greatly despite worldwide efforts to reg...
Synthesized in early 1990s in pharmaceutical research, designer cannabinoids show high affinity at e...
New psychoactive substances are becoming increasingly common in many parts of the world, and some of...
The main analytical targets of synthetic cannabinoids are often metabolites. With the high number of...
Synthetic cannabinoids (SCs) represented 45% of new psychoactive substances seizures in Europe (data...
Synthetic cannabinoids (SCs) represented 45% of new psychoactive substances seizures in Europe (data...
New psychoactive substances (NPS) are emerging in the illegal drug market, which has led to major ch...
Synthetic cannabinoids are a class of novel psychoactive substances originally developed to explore ...
Clandestine laboratories continue producing new synthetic cannabinoids that mimic and magnify natura...
noids have been abused as recreational drugs, prompt-ing scheduling of these substances in many coun...
Purpose New generations of synthetic cannabinoids (SCs) have recognized strong psychoactive effects,...
The drug abuse epidemic within the United States remains one of the nation’s most serious social cha...
ADB-CHMINACA (MAB-CHMINACA) is a new synthetic cannabinoid with high potency and many reported adver...
BACKGROUND: ADB-PINACA and its 5-fluoropentyl analog 5F-ADB-PINACA are among the most potent synthet...
Synthetic cannabinoids are one of the most significant groups within the category new psychoactive s...
Recently, use of novel synthetic cannabinoids has increased greatly despite worldwide efforts to reg...
Synthesized in early 1990s in pharmaceutical research, designer cannabinoids show high affinity at e...